scholarly article | Q13442814 |
P50 | author | Samir Mitragotri | Q7409527 |
P2093 | author name string | Elizabeth Chambers | |
P433 | issue | 7 | |
P921 | main subject | nanoparticle | Q61231 |
P304 | page(s) | 958-966 | |
P577 | publication date | 2007-07-01 | |
P1433 | published in | Experimental Biology and Medicine | Q15716535 |
P1476 | title | Long circulating nanoparticles via adhesion on red blood cells: mechanism and extended circulation | |
P478 | volume | 232 |
Q90207123 | A Review of Controlled Drug Delivery Systems Based on Cells and Cell Membranes |
Q37896455 | Bio-inspired, bioengineered and biomimetic drug delivery carriers |
Q28080710 | Cell or cell membrane-based drug delivery systems |
Q34079604 | Cell-mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles |
Q34424045 | Co-opting biology to deliver drugs |
Q39458957 | Complex effects of tumor microenvironment on the tumor disposition of carrier-mediated agents |
Q34028841 | Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells. |
Q26774341 | Drug carriers based on highly protein-resistant materials for prolonged in vivo circulation time |
Q37700751 | Drug delivery by red blood cells: vascular carriers designed by mother nature |
Q38123856 | Engineering antiphagocytic biomimetic drug carriers |
Q35142623 | Enhancing Cell therapies from the Outside In: Cell Surface Engineering Using Synthetic Nanomaterials |
Q92875756 | Erythrocyte Membrane Cloaked Curcumin-Loaded Nanoparticles for Enhanced Chemotherapy |
Q52653941 | Harnessing Biology to Deliver Therapeutic and Imaging Entities via Cell-Based Methods. |
Q36920492 | Hybrid nanoparticles improve targeting to inflammatory macrophages through phagocytic signals. |
Q92257562 | Impact of Nanocapsules on Red Blood Cells Interplay Jointly Assessed by Optical Tweezers and Microscopy |
Q35576287 | Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes |
Q41470605 | Intravenous hemostat: nanotechnology to halt bleeding. |
Q36005980 | Macrophage engulfment of a cell or nanoparticle is regulated by unavoidable opsonization, a species-specific 'Marker of Self' CD47, and target physical properties |
Q35710697 | Modelling the Transport of Nanoparticles under Blood Flow using an Agent-based Approach |
Q28393482 | Multi-walled carbon nanotube-induced inflammatory response and oxidative stress in a dynamic cell growth environment |
Q88204108 | Nano-Engineered Mesenchymal Stem Cells Increase Therapeutic Efficacy of Anticancer Drug Through True Active Tumor Targeting |
Q39564643 | Nanoparticulate cellular patches for cell-mediated tumoritropic delivery |
Q57381723 | Polymeric carriers: role of geometry in drug delivery |
Q38760096 | Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems |
Q42028534 | Soluble urokinase receptor conjugated to carrier red blood cells binds latent pro-urokinase and alters its functional profile |
Q39037485 | Surface engineering tumor cells with adjuvant-loaded particles for use as cancer vaccines |
Q28550941 | The Effect of Polymeric Nanoparticles on Biocompatibility of Carrier Red Blood Cells |
Search more.